Dry Eye Disease in India: The Screen-Time Epidemic and What Actually Helps

India is experiencing a quiet epidemic of ocular surface disease, and its primary driver sits in every pocket and on every desk. As smartphone penetration, remote work and digital education have exploded, Indian clinical studies are documenting rates of dry eye disease (DED) and digital eye strain (DES) that would have seemed implausible a decade ago. For ophthalmologists, this is a daily clinic reality; for pharmacies and distributors, it is a structural shift in demand toward lubricants; and for hundreds of millions of screen users, it is a comfort-and-productivity problem that too often goes unmanaged.

This article summarises the Indian evidence, explains the mechanism, and outlines what genuinely helps — from blink discipline to the lubricant ladder.

The Indian Evidence: What the Numbers Show

Indian data on screen-associated dry eye has accumulated rapidly:

• University students: A 2026 Chennai study of over 1,000 undergraduates (Frontiers in Public Health) found 94.1% reported at least one symptom and 73.7% met validated criteria for digital eye strain (CVS-Q ≥ 6), with symptom burden rising progressively with daily screen hours. Earlier Indian student studies reported DES prevalence in the 50–77% range.
• Office workers: A 2025 Bengaluru study of 460 office workers using digital screens found dry eye syndrome in 53.9%, confirmed by clinical tests (tear break-up time and Schirmer's) — rising from 39% among those on screens 6–7 hours daily to 69.4% among those exceeding nine hours. Low humidity and close viewing distance were independent risk factors.
• Adolescents: A 2022 Nellore study found DES symptoms in nearly two-thirds of school-aged screen users, with objectively measured blink rate falling as screen time rose.
• Background prevalence: Community studies put overall dry eye prevalence in India in the broad range of roughly one in five adults, with urban, air-conditioned, screen-intensive populations far higher.

The pattern is consistent across studies: more continuous screen hours, worse symptoms and signs — a genuine dose-response relationship. Equally consistent is the age shift: dry eye, once framed as a disease of post-menopausal women and the elderly, is now appearing in clinics among patients in their twenties with no risk factor except ten hours of daily screen exposure. That demographic change alone rewrites the market and the clinical playbook for the next decade.

Why Screens Dry Out Eyes

The mechanism is now well characterised:

1. Blink suppression. Normal spontaneous blinking runs about 15–20 times per minute, spreading a fresh tear film across the cornea each time. Sustained screen attention cuts this dramatically — studies show blink rates can halve or worse, and incomplete blinks (where the lids never fully close) increase.
2. Tear film instability. Each blink renews the three-layer tear film — lipid (from meibomian glands), aqueous and mucin. Too few blinks means longer exposure between renewals, faster evaporation, tear break-up, and localised dry spots on the cornea.
3. Environmental amplifiers. Air conditioning and fans lower humidity and accelerate evaporation; screen position above eye level widens the palpebral aperture and the exposed surface; glare and poor ergonomics add muscular strain to the surface problem.
4. The inflammatory loop. Chronic tear hyperosmolarity triggers ocular surface inflammation, which further destabilises the tear film — the self-perpetuating cycle at the heart of the TFOS DEWS II definition of dry eye disease.

Symptoms follow predictably: burning, grittiness and foreign-body sensation, redness, intermittent blur that clears with blinking, paradoxical watering (reflex tearing), end-of-day fatigue and headache.

DED vs DES: Related but Not Identical

Worth clarifying for precision: digital eye strain (computer vision syndrome) is a symptom cluster — ocular discomfort plus headache, neck pain and focusing difficulty — that occurs during or after screen use. Dry eye disease is a clinical condition with measurable signs: reduced tear break-up time, abnormal Schirmer's or osmolarity, surface staining. Heavy screen use causes DES in most people and measurable DED in a large subset. The practical management overlaps heavily.

What Actually Helps: A Tiered Approach

Tier 1 — Behaviour and environment (free, effective, underused)

• The 20-20-20 rule: every 20 minutes, look at something ~20 feet away for 20 seconds. It resets blink patterns and accommodative spasm.
• Conscious blinking: periodic full, gentle lid closures — especially during reading-heavy work.
• Screen ergonomics: screen slightly below eye level (narrower aperture, less exposure), arm's-length distance, reduced glare, humidity preserved where possible; avoid fans and AC drafts aimed at the face.
• Hard stops: continuous screen sessions beyond 60–90 minutes without a break are where symptoms compound; the Chennai data showed risk climbing steeply past 6 and especially 10 daily hours.

Tier 2 — Lubricants (the pharmacological mainstay)

Artificial tears remain first-line therapy, and choosing among them is a matching exercise:

The preservative point deserves emphasis: patients instilling drops 4–6+ times daily for months should not be adding chronic benzalkonium chloride exposure to an already inflamed surface — TFOS DEWS II lists preservative toxicity among the iatrogenic drivers of dry eye. Preservative-free unit doses or multidose systems are the rational choice for heavy users.

Tier 3 — When to escalate

Refer or escalate when symptoms persist despite lubricants and behaviour change, or when signs are significant: meibomian gland dysfunction needs lid hygiene, warm compresses and sometimes in-office therapy; moderate-severe inflammatory DED may warrant prescription anti-inflammatories (cyclosporine, lifitegrast, short steroid pulses) under ophthalmologist supervision; punctal occlusion and autologous serum sit further up the ladder. Screen-driven dryness unresponsive to basic measures deserves a slit-lamp evaluation, not just a stronger tear.

Two Faces of Dry Eye: Aqueous-Deficient vs Evaporative

TFOS DEWS II — the international consensus report that anchors modern dry eye practice — classifies DED along a spectrum between aqueous-deficient dry eye (the lacrimal glands underproduce the watery layer; seen with ageing, autoimmune disease like Sjögren's, and some medications) and evaporative dry eye (the tear film evaporates too fast, usually because meibomian glands in the eyelids under-deliver the protective lipid layer). Screen-associated dry eye sits mostly on the evaporative side: blink suppression both reduces lipid spreading and lengthens exposure time. The distinction matters practically because it directs treatment — lipid-supporting measures and lid hygiene for evaporative disease, higher-viscosity and hyaluronate lubricants for aqueous deficiency — and most real patients have a mix of both, which is why combination strategies outperform any single drop. It also explains why "my eyes water constantly" is a dry-eye symptom, not a contradiction: a destabilised tear film triggers reflex tearing that never resolves the underlying osmolarity problem.

Special Situations in the Indian Context

Several factors make Indian dry eye management more than a copy of Western guidance:

• Climate extremes. Hot, dry seasons accelerate evaporation outdoors while aggressive air conditioning does the same indoors; monsoon humidity offers the only natural relief. Lubricant demand and dosing frequency track the calendar.
• Two-wheeler commuting. Dust, wind and pollution exposure on open commutes add an environmental load uncommon in car-centric markets — wraparound eyewear is a genuinely useful intervention here.
• Contact lens wear is growing among urban young adults; lens wear with screen-heavy days is a compounded risk, and rewetting drops compatible with lenses belong in the conversation.
• Self-medication culture. Decongestant "redness relief" drops sold over the counter mask symptoms while causing rebound congestion and no tear-film benefit — a counselling point every pharmacist and ophthalmologist should press.
• Post-surgical and post-LASIK dryness. India's huge refractive and cataract surgery volumes generate a secondary dry-eye population needing structured lubricant courses, often preservative-free, for weeks to months.

For Workplaces and Campuses

The Bengaluru office-worker data (53.9% dry eye prevalence) makes dry eye an occupational health issue. Practical institutional measures include humidification targets in AC environments, anti-glare screen policies, enforced micro-breaks in high-screen roles, and lubricant availability in workplace health kits. Corporate health programmes that include eye screening increasingly surface undiagnosed dry eye at scale — an emerging channel for both awareness and appropriate product use.

What This Means for the Supply Side

The commercial translation for pharmacies, hospitals and distributors is straightforward: lubricants are no longer an occasional purchase — they are a chronic, high-velocity category with a widening base of younger users. A rational lubricant shelf mirrors the clinical ladder: an everyday CMC line, a hyaluronate step-up, a gel for night-time, and preservative-free options for chronic users. Facilities serving corporate health programmes and campus clinics are increasingly stocking all four rungs.

Frequently Asked Questions

Is dry eye from screens permanent?

Usually not, if caught early. Screen-related tear film dysfunction is largely behavioural and environmental, and typically improves substantially with blink discipline, breaks, ergonomics and lubricants. However, years of unaddressed evaporative stress can produce meibomian gland dropout and chronic inflammatory DED, which is harder to reverse — one more reason to manage symptoms early rather than endure them.

How common is digital eye strain in India really?

Very common. Recent Indian studies report validated DES in roughly 50–74% of university students and dry eye disease in over half of urban office workers, with prevalence climbing steeply beyond 6–9 hours of daily screen time. Methodologies differ between studies, but the direction and scale are consistent.

Which artificial tear should I use for screen-related dryness?

For mild, occasional symptoms, a standard CMC 0.5% tear used a few times daily is a sensible start. If dosing exceeds 3–4 times daily or symptoms persist, step up to sodium hyaluronate for longer residence, add a gel at night, and switch to preservative-free formulations for chronic frequent use. An ophthalmologist should guide anything beyond the mild tier.

Do blue-light glasses prevent dry eye?

There is no good evidence that blue-light-filtering lenses prevent or treat dry eye. The dryness mechanism is blink suppression and evaporation, not retinal light damage. Breaks, blink training, ergonomics and lubricants address the actual mechanism.

When should screen-related eye symptoms see a doctor?

Seek an ophthalmologist if symptoms persist beyond 2–4 weeks despite breaks and lubricants, if vision fluctuates or declines, if there is pain, significant redness, discharge or light sensitivity, or if one eye is notably worse — those features suggest something beyond simple screen dryness.

---

This article is for general education and does not constitute medical advice. Persistent eye symptoms should be evaluated by a qualified ophthalmologist.

Stocking the dry eye category? Explore the Ocufina and Restor lubricant range — request samples or become a distributor.